School of Life Sciences, Zhengzhou University, Science Avenue 100#, Zhengzhou 450001, China.
Department of Molecular Pathology, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450001, China.
ACS Appl Mater Interfaces. 2023 Aug 16;15(32):38294-38308. doi: 10.1021/acsami.3c06909. Epub 2023 Aug 5.
Loading hyaluronidase (Hyal) in a nanocarrier is a potent strategy to degrade the tumor extracellular matrix for tumor deep penetration and enhanced tumor therapy. Herein, a pH-sensitive biomimicking nanosystem with high Hyal loading, effective tumor targeting, and controllable release is constructed. Specifically, cationic mesoporous silica nanoparticles (CMSNs) with large pores 13.52 nm in diameter were synthesized in a one-pot manner by adding -[3-trimethoxysilylpropyl]-,,-trimethylammonium to a reversed microemulsion reaction system. The Hyal loading rate was as high as 19.47% owing to matched pore size and the cationic surface charge. Subsequently, a pH-sensitive biomimetic hybrid membrane (pHH) composed of pH-sensitive liposome (pHL), red blood cell membrane, and pancreatic cancer cell membrane was camouflaged on the pHL-coated and doxorubicin/Hyal-loaded CMSNs (shortened as DHCM). The DHCM@pHL@pHH is stable at neutral pH while it releases the payloads smoothly in the tumor acidic microenvironment. Consequently, it can escape from macrophage clearance, be specifically taken up by pancreatic cancer cells, and efficiently accumulate at the tumor site. More importantly, it can penetrate deeply in pancreatic tumors with a tumor growth inhibition ratio of 80.46%. The nanosystem is biocompatible and has potential for clinical transformation, and the nanocarrier is promisingly applicable as a platform for encapsulation of various macromolecules for smart and tumor-targeted delivery.
将透明质酸酶(Hyal)载入纳米载体是一种有效策略,可用于降解肿瘤细胞外基质,以实现肿瘤的深层渗透和增强肿瘤治疗效果。在此,构建了一种具有高透明质酸酶载量、有效肿瘤靶向和可控释放的 pH 敏感仿生纳米系统。具体而言,通过在反相微乳液反应体系中添加-[3-三甲氧基硅丙基]-、-[2-羟丙基]-、-三甲基氯化铵,一步法合成了孔径为 13.52nm 的大孔阳离子介孔硅纳米颗粒(CMSNs)。由于匹配的孔径和阳离子表面电荷,透明质酸酶的载量率高达 19.47%。随后,pH 敏感仿生混合膜(pHH)由 pH 敏感脂质体(pHL)、红细胞膜和胰腺癌细胞膜组成,被伪装在 pHL 涂层和阿霉素/透明质酸酶载入的 CMSNs(缩写为 DHCM)上。DHCM@pHL@pHH 在中性 pH 下稳定,而在肿瘤酸性微环境中能顺利释放载药。因此,它可以逃避巨噬细胞的清除,被胰腺癌细胞特异性摄取,并有效地聚集在肿瘤部位。更重要的是,它可以在胰腺肿瘤中实现深度渗透,肿瘤生长抑制率达到 80.46%。该纳米系统具有良好的生物相容性,有潜在的临床转化前景,该纳米载体有望作为一种封装各种大分子的平台,用于智能和肿瘤靶向递药。